A class action lawsuit has been initiated against PomDoctor, Ltd. (NASDAQ: POM), with allegations that company defendants engaged in materially false statements and omitted critical disclosures regarding an orchestrated stock promotion scheme. According to the complaint, the scheme involved coordinated social media misinformation campaigns, insider share sales through offshore accounts, and artificially inflated trading activity designed to manipulate the company's stock price.
The litigation covers investors who purchased PomDoctor securities during a specific window spanning from October 9, 2025 through December 11, 2025. The class action, filed by Bronstein, Gewirtz & Grossman LLC, seeks to recover damages allegedly sustained by shareholders during this period of nondisclosure and misrepresentation.
Investors affected by purchases during the specified timeframe are urged to take action, with a lead plaintiff deadline established for April 6, 2026. The case represents an effort to hold company leadership accountable for the alleged breach of fiduciary duties and securities law violations.